Free Trial

DocuSign (NASDAQ:DOCU) to Buyback $1.00 billion in Outstanding Stock

DocuSign logo with Computer and Technology background

DocuSign (NASDAQ:DOCU - Get Free Report) declared that its board has approved a share buyback plan on Thursday, June 5th, RTT News reports. The company plans to repurchase $1.00 billion in outstanding shares. This repurchase authorization permits the company to reacquire up to 6.6% of its shares through open market purchases. Shares repurchase plans are usually an indication that the company's leadership believes its shares are undervalued.

DocuSign Trading Down 19.0%

Shares of NASDAQ:DOCU traded down $17.62 on Friday, reaching $75.28. 22,572,298 shares of the company traded hands, compared to its average volume of 2,857,113. The business's 50-day simple moving average is $82.23 and its 200 day simple moving average is $86.25. DocuSign has a 52 week low of $48.70 and a 52 week high of $107.86. The stock has a market capitalization of $15.24 billion, a P/E ratio of 15.52, a price-to-earnings-growth ratio of 6.94 and a beta of 1.21.

DocuSign (NASDAQ:DOCU - Get Free Report) last announced its quarterly earnings data on Thursday, June 5th. The company reported $0.90 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.81 by $0.09. The firm had revenue of $763.65 million for the quarter, compared to analysts' expectations of $748.79 million. DocuSign had a return on equity of 14.90% and a net margin of 34.73%. The company's revenue for the quarter was up 7.6% compared to the same quarter last year. During the same period last year, the firm earned $0.82 earnings per share. Sell-side analysts expect that DocuSign will post 1.17 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

DOCU has been the topic of a number of research analyst reports. JMP Securities reissued a "market outperform" rating and issued a $124.00 target price on shares of DocuSign in a research note on Tuesday. Citigroup increased their target price on DocuSign from $113.00 to $115.00 and gave the company a "buy" rating in a research note on Friday, March 14th. Robert W. Baird reduced their target price on DocuSign from $93.00 to $85.00 and set a "neutral" rating on the stock in a research note on Friday. Royal Bank of Canada reissued a "sector perform" rating and issued a $90.00 target price on shares of DocuSign in a research note on Friday, March 14th. Finally, Morgan Stanley reduced their target price on DocuSign from $92.00 to $86.00 and set an "equal weight" rating on the stock in a research note on Friday. One analyst has rated the stock with a sell rating, eleven have given a hold rating and four have issued a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $89.15.

Get Our Latest Report on DOCU

Insider Transactions at DocuSign

In other news, insider Robert Chatwani sold 15,706 shares of the stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $83.19, for a total transaction of $1,306,582.14. Following the completion of the sale, the insider now directly owns 76,842 shares in the company, valued at approximately $6,392,485.98. This represents a 16.97% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Blake Jeffrey Grayson sold 8,000 shares of the stock in a transaction dated Tuesday, April 15th. The stock was sold at an average price of $76.09, for a total transaction of $608,720.00. Following the sale, the chief financial officer now owns 86,156 shares of the company's stock, valued at approximately $6,555,610.04. This represents a 8.50% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 47,851 shares of company stock worth $3,912,239. Company insiders own 1.01% of the company's stock.

About DocuSign

(Get Free Report)

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in DocuSign Right Now?

Before you consider DocuSign, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocuSign wasn't on the list.

While DocuSign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Congress Is Pouring Millions Into These 6 Surprising Stocks
3 Dirt-Cheap Stocks in a Market That’s Getting Expensive
Top 3 Defense Stocks to Profit From $175 Billion Golden Dome

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines